Flow Neuroscience has introduced an innovative FDA-approved headset device designed to alleviate depression symptoms and potentially reduce dependence on antidepressant medications. This breakthrough neurotechnology uses transcranial magnetic stimulation to target brain activity associated with mood disorders. While the device offers a promising alternative treatment option for individuals struggling with depression, accessibility remains a challenge due to its $2,200 price point. Healthcare providers and patients are now exploring whether this non-pharmaceutical approach could complement or replace traditional antidepressant therapy.

Summary auto-generated by AI from the original publisher's content. Editorial standards.